What are the effects of osimertinib mesylate tablets?

Osimertinib mesylate tablets (Osimertinib) is a targeted therapy drug for non-small cell lung cancer (NSCLC). Its main function is to block the growth and spread of tumors by inhibiting the epidermal growth factor receptor (EGFR) in tumor cells. The following is a detailed introduction to the mechanism of action and effects of Osimertinib Mesylate Tablets:

1.EGFRTyrosine kinase inhibition: mesylateOsimertinib tablets is a highly selective EGFRtyrosine kinase inhibitor. EGFR is a receptor tyrosine kinase located on the cell membrane, involved in regulating key physiological processes such as cell growth, proliferation and survival. Osimertinib/Osimertinib tablets can interact with the ATP binding site of EGFR and inhibit its activity, thus blocking the conduction of the EGFR signaling pathway.

2. Targeting specificEGFR mutations: mesylate Osimertinib tablets are mainly used to treat EGFR Patients with NSCLC who have positive gene mutations, especially those who are resistant to other EGFR inhibitors. It can target EGFR gene mutations, such as EGFR sensitive mutations (such as Del19 and L858R) and EGFR T790M mutation exerts its inhibitory effect.

3.Overcoming drug resistance: During NSCLC treatment, patients may develop resistance to other EGFR inhibitors. One of the common resistance mutations isEGFR T790M mutation. Osimertinib mesylate tablets have high selectivity, especially for the EGFR T790M mutation, and can overcome the resistance of other EGFR inhibitors, thereby improving the therapeutic effect.

4.Brain metastasis treatment: Osimertinib mesylate tablets have good intracerebral permeability, can effectively cross the blood-brain barrier, inhibit the growth and spread of brain metastases, and provide an effective brain metastasis treatment option for patients with advanced NSCLC patients.

In general, osimertinib mesylate tablets interfere with the growth and spread of tumor cells by specifically inhibiting the EGFR signaling pathway, thereby exerting its targeted therapeutic effect on NSCLC. Its mechanism of action mainly includes EGFR tyrosine kinase inhibition, targeting specific EGFR mutations, overcoming drug resistance and brain metastasis treatment. These effects make Osimertinib mesylate/osimertinib tablets an important treatment option for patients with advanced NSCLC, improving their survival rate and quality of life.